Changing patterns of antidepressant use and costs in a health maintenance organisation

PharmacoEconomics

Volumn 11, Issue 3, 1997, Pages 274-286

  Johnson, Richard E ^a   McFarland, Bentson H ^a   Nichols, Gregory A ^a  

^a CENTER FOR HEALTH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; FLUOXETINE; IMIPRAMINE; ISOCARBOXAZID; MAPROTILINE; MONOAMINE OXIDASE INHIBITOR; NORTRIPTYLINE; PAROXETINE; PHENELZINE; PROTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DRUG COST; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL;

EID: 0031039301     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199711030-00008     Document Type: Article

References (25)

1. Langreth R. High anxiety: rivals threaten Prozac. Wall St J 1996 May 9; B1-2
2. The Treatment of Depression in Primary Care. Leeds: University of Leeds, 1993 Effective Health Care Bulletin no. 5
3. Song F, Freemantle N, Sheldon T, et al. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. BMJ 1993; 306: 683-7
4. Smith HA, Wedlund PJ. Depression: its classification, epidemiology, expression and treatment. J Pharmacoepidemiol 1993; 2: 3-34
5. Anderson IM, Tomenson BM. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. BMJ 1995; 310: 1433-8
6. Montgomery SA, Kasper S. Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. Int Clin Psychopharmacol 1995; 9 Suppl 4: 33-40
7. Gram LF. Fluoxetine. N Engl J Med 1994; 331: 1354-61
8. Balon, R, Yeragani VK, Pohl R, et al. Sexual dysfunction during antidepressant treatment. J Clin Psychiatry 1993; 54: 209-12
9. Seagraves RT. Overview of sexual dysfunction complicating the treatment of depression. J Clin Psychiatry 1992; 10: 4-10
10. Katon W, VonKorff M, Lin E, et al. Adequacy and duration of antidepressant treatment in primary care. Med Care 1992; 30: 67-76
11. Simon G, VonKorff M, Wagner EH, et al. Patterns of antidepressant use in community practice. Gen Hosp Psychiatry 1993; 15: 399-408
12. McFarland BH. Cost-effectiveness considerations for managed care systems: treating depression in primary care. Am J Psychiatry 1994; 97 Suppl. 6A: 47S-57S
13. Jick SS, Dean DD, Jick H. Antidepressants and suicide. BMJ 1995; 310: 215-8
14. Harrison G. New or old antidepressants? New is better. BMJ 1994; 309: 1280-1
15. Owens D. Benefits of new drugs are exaggerated. BMJ 1994; 309: 1281-2
16. Sclar DA, Robison LM, Skaer TL, et al. Antidepressant pharmacotherapy: economic outcomes in a health maintenance organization. Clin Ther 1994; 16: 715-30
17. Skaer T, Sclar DA, Robison LM, et al. Economic evaluation of amitriptyline, desipramine, nortriptyline, and sertraline in the management of depression. Curr Ther Res 1995; 56: 556-67
18. Jonsson B, Bebbington PE. What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment. Br J Psychiatry 1994; 164: 665-73
19. Bentkover JD, Feighner JP. Cost analysis of paroxetine versus imipramine in major depression. Pharmacoeconomics 1995; 8: 223-32
20. Wilde MI, Whittington R. Paroxetine - a pharmacoeconomic evaluation of its use in depression. Pharmacoeconomics 1995; 8: 62-81
21. Simon GE, VonKorff M, Heiligenstein JH, et al. Initial antidepressant choice in primary care - effectiveness and cost of fluoxetine vs tricyclic antidepressants. JAMA 1996; 275: 1897-902
22. Donoghue J, Tylee A, Wildqust H. Cross sectional database analysis of antidepressant prescribing in general practice in the United Kingdom, 1993-1995. BMJ 1996; 313: 861
23. Physicians Desk Reference. 49th ed. Oradell (NJ): Medical Economics Company, Inc., 1995
24. Keller MB, Klerman GL, Lavori PW, et al. Treatment received by depressed patients. JAMA 1982; 248: 1848-55
25. Keller MB, Lavori PW, Klerman GL, et al. Low levels and lack of predictors of somatotherapy and psychotherapy received by depressed patients. Arch Gen Psychiatry 1986; 43: 458-466